Weiss & Lurie, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Blue Coat Systems, Inc. (“Blue Coat” or the “Company”) (Nasdaq: BCSI) arising from its agreement to be acquired by an investor group led by San Francisco based private equity investment firm Thoma Bravo, LLC (“Thoma”). Under the terms of the definitive agreement, Blue Coat shareholders will receive $25.81 cash per share. The proposed transaction has a total value of $1.3 billion.
Weiss & Lurie is investigating whether Blue Coat’s Board acted in the best interests of its shareholders in approving the transaction, including whether the consideration being paid to shareholders is fair in light of the true inherent value of the Company. The Company’s stock traded at levels that exceeded $32.00 per share as recently as January 2011, and at least one analyst has valued the Company at $28.00 per share. The investigation also focuses on whether the Board’s “review of all strategic options” prior to the agreement included an adequate sales process.
If you own Blue Coat shares and would like more information about your rights as a shareholder or additional information concerning our investigation, please contact Richard A. Acocelli either by email at
or by telephone at (888) 593-4771.
Weiss & Lurie has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded institutions and individuals and obtained important corporate governance in these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or issuing materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at
or fill out the form on our website,
Advertising. Past results do not guarantee a similar outcome.